Royalty Pharma plc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.4 | $2.3 | $2.4 | $2.2 | $2.3 |
| Operating income | $1.6 | $1.3 | $1.5 | $0.3 | $1.4 |
| Net income | $0.8 | $0.9 | $1.1 | $<0.1 | $0.6 |
| Cash Flow Statement | |||||
| Share repurchases | $1.2 | $0.2 | $0.3 | $0.0 | $0.0 |
Shares outstanding 575.0M · Free float 69.9%
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.